K5 Therapeutics (Private limited company)
K5 Therapeutics is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0757.718.072. It was founded on 02-11-2020. Its registered office is in Leuven. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € 2 959 218 and a profit of € 261 735. These accounts report 17.8 full-time equivalents. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.
Information last updated on 17-10-2026.
Company information
Key figures of K5 Therapeutics
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € 261 735+39 % | € 187 917+51 % | € 124 322-86 % | € 885 725 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € 2 959 218+10 % | € 2 697 483+7 % | € 2 509 566+5 % | € 2 385 244 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 3 559 001+9 % | € 3 258 881+2 % | € 3 208 893+10 % | € 2 909 098 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € 2 632 342+43 % | € 1 846 089+36 % | € 1 359 753+11 % | € 1 224 339 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | 17.8+32 % | 13.5+27 % | 10.6+293 % | 2.7 |
Financial estimate
Similar companies
Other companies in the same activity in Leuven.
| Company | Town |
|---|---|
| NELSON LABS | 3001 Leuven |
| CUE - GRAPHICS | 3001 Leuven |
| Antleron | 3001 Leuven |
| RAMDESIGN | 3001 Leuven |
| LIMITO | 3001 Leuven |
| BETTER3FRUIT | 3001 Leuven |
| HUAWEI TECHNOLOGIES RESEARCH & DEVELOPMENT BELGIUM | 3001 Leuven |
| reMYND | 3001 Leuven |
Frequently asked questions
Is K5 Therapeutics still active? Yes. The Crossroads Bank for Enterprises lists K5 Therapeutics as active.
What is the VAT number of K5 Therapeutics? The VAT number of K5 Therapeutics is BE 0757.718.072.
When was K5 Therapeutics founded? K5 Therapeutics was founded on 02-11-2020.
What is the address of K5 Therapeutics? The current registered office of K5 Therapeutics is Gaston Geenslaan 3, 3001 Louvain.
When did K5 Therapeutics last file annual accounts? The latest annual accounts of K5 Therapeutics were filed on 11-06-2026.
Does K5 Therapeutics file its annual accounts on time? Yes. K5 Therapeutics filed its annual accounts within the legal deadline for each of its last 4 financial years.
How many employees does K5 Therapeutics have? K5 Therapeutics employs 17.8 full-time equivalents according to its most recent annual accounts.
Is K5 Therapeutics financially healthy? Addrly gives K5 Therapeutics a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is K5 Therapeutics profitable? The annual accounts of K5 Therapeutics for 2025 show a profit of € 261 735.
What is the equity of K5 Therapeutics? The equity of K5 Therapeutics was € 2 959 218 at the close of the 2025 financial year.
Who are the directors of K5 Therapeutics? The annual accounts of K5 Therapeutics record 3 mandates. The names, roles and dates are visible with a free account.
Can K5 Therapeutics receive Peppol e-invoices? Yes. K5 Therapeutics is registered on the Peppol network and can receive structured electronic invoices.
What does K5 Therapeutics do? The main activity of K5 Therapeutics is: Scientific research and development.